The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s respiratory disease testing market report forecasts the respiratory disease testing market size to grow to $4.07 Billion by 2027, with a CAGR (compound annual growth rate) of more than 4%.

Learn More On The Respiratory Disease Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/respiratory-disease-testing-global-market-report

Respiratory Disease Testing Market Size Forecast
The global respiratory disease testing market is expected to grow from $3.26 billion in 2022 to $3.42 billion in 2023 at a compound annual growth rate (CAGR) of 4.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The global respiratory disease testing market size is expected to reach $4.07 billion in 2027 at a CAGR of 4.4%.

North America held the largest respiratory disease testing market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Respiratory Disease Testing Market Driver ­– Rise In The Prevalence Of Respiratory Diseases
According to the NCD Alliance, a Swiss-based civil society organisation, lung cancer will be the main cause of cancer deaths in September 2022, with 2.2 million new cases and 1.8 million fatalities expected year on year. Furthermore, chronic respiratory illnesses affected 550 million adults worldwide, and 4.2 million individuals died, accounting for 7% of all deaths. As a result, the increased prevalence of respiratory disorders will propel the market for respiratory disease testing ahead.

Request for A Sample Of The Global Respiratory Disease Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10304&type=smp

Key Respiratory Disease Testing Market Trend – Technological Advancement
To strengthen their market position, major respiratory illness testing companies are focusing on creating artificial intelligence and machine learning technologies to optimise treatment regimens and improve patient outcomes. For example, Respira Labs, a US-based healthcare technology startup, launched Sylvee, an AI-powered wearable device for monitoring lung function, in March 2022. The device is designed to be worn as a chest strap and analyses data from several sensors that detect breathing rate, volume, and patterns using AI and machine learning algorithms. It can aid in the early diagnosis and management of chronic obstructive pulmonary disease (COPD), asthma, and COVID-19, and it employs powerful artificial intelligence (AI) algorithms to analyse breath sounds and provide real-time feedback on lung function.

Respiratory Disease Testing Market Segment
1) By Test Type: Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests
2) By Products: Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Products
3) By Application: Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis Female, Other Application
4) By End-User: Hospitals, Physician clinics, Clinical laboratories, Other End-User

Respiratory Disease Testing Market Major Players and Strategies
Major players in the respiratory disease testing market are Medtronic plc, Carestream Medical Ltd., Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company (BD), F. Hoffmann-La Roche Ltd., Alere Inc., Nihon Kohden Corporation, GE HealthCare Technologies Inc., CareFusion Corporation, Merck And Co. Inc., Fisher And Paykel Healthcare Corporation Limited, and Qiagen N.V.

CAIRE Inc., a medical supply and manufacturing firm based in the United States, paid an unknown sum for MGC Diagnostics Holdings in January 2023. CAIRE Inc. hopes to broaden the scope of its product line, diversify its revenue sources by adding cardiorespiratory diagnostic devices to its portfolio, and strengthen its position as a market leader in medical technology for respiratory and cardiorespiratory diagnostics with this acquisition. MGC Diagnostics Holdings Inc. is a medical technology firm established in the United States that offers cardiorespiratory diagnostic solutions and respiratory illness testing devices.

The Respiratory Disease Testing Global Market Report 2023 covers regional data on respiratory disease testing market size, respiratory disease testing market trends and drivers, opportunities, strategies, and respiratory disease testing market competitor analysis. The countries covered in the respiratory disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The treatment procedure of testing for various respiratory disorders via physical examinations is referred to as respiratory disease testing. It assists a clinician in diagnosing respiratory disease even before a patient experiences symptoms by assessing the lung condition and measuring how fast it can blast air out.

View More Reports Related To The Respiratory Disease Testing Market –
Respiratory Disposables Global Market Report 2023
Respiratory Devices And Equipment (Therapeutic) Global Market Report 2023
Respiratory Monitoring Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: